Article

Refac Optical to join EyeMed program

Fort Lee, NJ-Refac Optical Group has reached an agreement with EyeMed Vision Care whereby Refac's U.S. Vision subsidiary would become a participating provider of managed care benefits in EyeMed's vision care networks.

Fort Lee, NJ-Refac Optical Group has reached an agreement with EyeMed Vision Care whereby Refac's U.S. Vision subsidiary would become a participating provider of managed care benefits in EyeMed's vision care networks.

The parties have agreed in principle that U.S. Vision will become a participating provider in the EyeMed Access and Select plans under an agreement that generally terminates on Dec. 31, 2010. The EyeMed network consists of optometrists, ophthalmologists, opticians, and many optical retailers including LensCrafters, Target Optical, and most Sears Optical and Pearle Vision locations.

"The new arrangement will provide us with more access to a much larger base of membership than we enjoyed under the Cole Managed Vision (CMV) plans with a longer term and a relationship with what we consider to be the premier managed care plan in the United States," said J. David Pierson, president and chief executive officer of Refac Optical Group.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.